Seeking Alpha

Teva Pharmaceutical (TEVA +0.3%) says the FDA has approved its Abbreviated New Drug Application...

Teva Pharmaceutical (TEVA +0.3%) says the FDA has approved its Abbreviated New Drug Application for the generic version of Shire's (SHPG) Adderall XR capsules for the treatment of ADD. Adderall XR had annual sales, including brand and generic sales, of approximately $2B in the U.S. last year.
Comments (5)
  • Michael Bryant
    , contributor
    Comments (5528) | Send Message
     
    (TEVA) is undervalued.
    14 Feb 2013, 03:36 PM Reply Like
  • chopchop0
    , contributor
    Comments (3301) | Send Message
     
    It's been "undervalued" for the last several quarters.
    14 Feb 2013, 04:14 PM Reply Like
  • Energysystems
    , contributor
    Comments (1071) | Send Message
     
    The only loser in my portfolio. Holding and DRIP'ing though, because I think the JV with PG will be a big winner in the long run.
    14 Feb 2013, 04:28 PM Reply Like
  • Michael Bryant
    , contributor
    Comments (5528) | Send Message
     
    I think main problem now is the climate surrounding Israel.
    14 Feb 2013, 06:11 PM Reply Like
  • Energysystems
    , contributor
    Comments (1071) | Send Message
     
    Plus they still have the upcoming Copaxone overhang, and that's a big bit of overall revenues. It's already put pressure on the stock price.
    14 Feb 2013, 06:17 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|